This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Arcosa (ACA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Arcosa (ACA) delivered earnings and revenue surprises of 7.14% and 4.99%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Arcosa (ACA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Arcosa (ACA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TopBuild (BLD) Banks on Acquisitions, Material Costs High
by Zacks Equity Research
Solid growth across the business, favorable industry parameters and strategic initiatives are aiding TopBuild (BLD) to generate higher profits despite high material cost.
New Strong Sell Stocks for June 17th
by Zacks Equity Research
CSIQ, SI, TTEC, ACA, and TUP have been added to the Zacks Rank #5 (Strong Sell) List on June 17, 2021
Arcosa (ACA) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Arcosa (ACA) delivered earnings and revenue surprises of 66.67% and 0.23%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Arcosa (ACA) Q1 Earnings Expected to Decline
by Zacks Equity Research
Arcosa (ACA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ACA vs. ROAD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ACA vs. ROAD: Which Stock Is the Better Value Option?
7 Low Price-to-Sales Stocks With Growth Potential to Own Now
by Zacks Equity Research
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
Arcosa (ACA) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Arcosa (ACA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Arcosa (ACA) Q3 Earnings Top Estimates
by Zacks Equity Research
Arcosa (ACA) delivered earnings and revenue surprises of 17.24% and -2.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Masco (MAS) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Masco's (MAS) third-quarter results gained from sturdy performance across both Plumbing Products and Decorative Architectural Products segments.
Armstrong World (AWI) Q3 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
Armstrong World's (AWI) third-quarter results are hurt by lower volume and unfavorable AUV.
Analysts Estimate Arcosa (ACA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Arcosa (ACA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Low Leverage Stocks to Buy for a Healthy Portfolio
by Aparajita Dutta
Although debt financing is more popular compared to equity financing, it remains a feasible option as long as the companies succeed in generating higher rate of return than the interest rate
7 Valuable Low Price-to-Sales Stocks With Growth Opportunity
by Rajani Lohia
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by a company.
Arcosa (ACA) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Arcosa (ACA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: LHCG, DKS, HMN, ACA and LL
by Zacks Equity Research
Zacks.com featured highlights include: LHCG, DKS, HMN, ACA and LL
Buy These 5 Low Leverage Stocks as Market Volatility Persists
by Aparajita Dutta
A total rebound of the market to the pre-pandemic levels is highly unlikely in the near future. Therefore, while choosing stocks, a prudent investor should avoid debt-ridden stocks
When Does Market Timing Actually Work? - September 30, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
ACA or AWI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ACA vs. AWI: Which Stock Is the Better Value Option?
Why TopBuild (BLD) is Rallying Significantly Post Q2 Earnings
by Zacks Equity Research
Solid growth across the business, favorable industry parameters and strategic initiatives are aiding TopBuild (BLD) to generate higher profits.
ACA vs. AWI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ACA vs. AWI: Which Stock Is the Better Value Option?
The Market Timing Secrets No One Talks About - September 10, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Keys to Successfully Timing the Markets - August 21, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
ACA vs. AWI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ACA vs. AWI: Which Stock Is the Better Value Option?